Elon Musk (Carina Johansen/NTB Scanpix via AP Images)

No­vo Nordisk, GSK pause some Twit­ter ad spend­ing af­ter Musk takeover

Eli Lil­ly isn’t the on­ly phar­ma com­pa­ny that’s paused ad­ver­tis­ing on Twit­ter in re­cent days.

No­vo Nordisk, one of the three ma­jor in­sulin drug­mak­ers along with Lil­ly and Sanofi, has halt­ed paid ad­ver­tis­ing on the so­cial me­dia site, End­points News has learned. Ad­di­tion­al­ly, GSK has en­act­ed a par­tial pause of Twit­ter ad­ver­tis­ing, stop­ping ads for spe­cif­ic prod­ucts but con­tin­u­ing to run “cor­po­rate” ad­ver­tise­ments.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.